Ancora Advisors, LLC Exact Sciences Corp Transaction History

Ancora Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $424 - $636	-9 Reduced 2.69%	325 $22,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $5,796 - $10,151	-191 Reduced 36.38%	334 $16,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $11,512 - $16,508	200 Added 61.54%	525 $37,000
Q1 2022 May 13, 2022	SELL	$57.56 - $82.54 $11,512 - $16,508	-200 Reduced 38.1%	325 $43,000
Q3 2021 Nov 15, 2021	BUY	$90.24 - $124.05 $18,048 - $24,810	200 Added 61.54%	525 $50,000
Q2 2020 Aug 14, 2020	SELL	$55.75 - $92.75 $14,104 - $23,465	-253 Reduced 43.77%	325 $28,000
Q1 2020 May 14, 2020	BUY	$37.9 - $104.44 $21,906 - $60,366	578 New	578 $34,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.